CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have No Effect on the Anti-Platelet Action of Clopidogrel

被引：0
|
作者：
El-Halabi, Mustapha [1 ]
Malli, Ahmad [1 ]
Mansour, Nabil [1 ]
Ghaith, Ola [1 ]
Saab, Rayan [1 ]
Mahfouz, Rami [1 ]
Alam, Samir [1 ]
Zgheib, Nathalie [1 ]
Sharara, Ala [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
120
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] CYP2C19 Genetic Polymorphism in Saudi Arabians
    Al-Jenoobi, Fahad I.
    Alkharfy, Khalid M.
    Alghamdi, Amal M.
    Bagulb, Khawla M.
    Al-Mohizea, Abdullah M.
    Al-Muhsen, Saleh
    Halwani, Rabih
    Parvez, Mohammad Khalid
    Al-Dosari, Mohammed S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (01) : 50 - 54
  • [32] Genetic Polymorphism of CYP2C19 in Pakistani Population
    Riaz, Sana
    Din, Sadia Muhammad
    Tareen, Muhammad Usman
    Tariq, Fizza
    Latif, Yusra
    Siddiqi, Saima
    Sultan, Aneesa
    Mansoor, Atika
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (02): : 1097 - 1102
  • [33] Effect of CYP2C19 Genotype On Control of Gastric Acidity with Rabeprazole and Esomeprazole After Single and Repeated Oral Administration
    Geus, William P.
    Hunfeld, Nicole G.
    Touw, Daan J.
    Sarmeel, Jesse T.
    Mulder, Paul G.
    GASTROENTEROLOGY, 2009, 136 (05) : A496 - A496
  • [34] CYP2C19*2 polymorphism contributes to a diminished pharmacodynamic response to clopidogrel
    Brandt, JT
    Kirkwood, S
    Mukhopadhyay, N
    Payne, CD
    Salazar, D
    Ernest, CS
    Winters, KJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 380A - 380A
  • [35] Protective effect of the CYP2C19*17 polymorphism with increased activation of clopidogrel on cardiovascular events
    Tiroch, Klaus A.
    Sibbing, Dirk
    Koch, Werner
    Roosen-Runge, Tobias
    Mehilli, Julinda
    Schoemig, Albert
    Kastrati, Adnan
    AMERICAN HEART JOURNAL, 2010, 160 (03) : 506 - 512
  • [36] The effect of CYP2C19 genotype on the platelet responsiveness to clopidogrel in healthy Korean subjects.
    Cho, D.
    Yeo, C.
    Oh, M.
    Shon, J.
    Kim, E.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S69 - S69
  • [37] Influence of CYP2C19 Polymorphism on Lansoprazole and Rabeprazole Maintenance Treatment of Reflux Esophagitis
    Koike, Tomoyuki
    Iijima, Katsunori
    Imatani, Akira
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2010, 138 (05) : S655 - S655
  • [38] Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
    Nawaz, Usman
    Noor, Mudassar
    Waheed, Akbar
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (12) : 2388 - 2392
  • [39] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
    Yu, KS
    Yim, DS
    Cho, JY
    Park, SS
    Park, JY
    Lee, KH
    Jang, IJ
    Yi, SY
    Bae, KS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 266 - 273
  • [40] Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms
    Chen, Bi-Lian
    Zhang, Wei
    Li, Qing
    Li, Ya-Lin
    He, Yi-Jing
    Fan, Lan
    Wang, Lian-Sheng
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (08) : 904 - 908
12345